SCOTTSDALE, AZ

Ben And Catherine Ivy Foundation

Quick Facts

EIN: 273322123
Location: SCOTTSDALE, AZ
Category: Philanthropy & Grantmaking
Total Assets: $299.8M
Annual Income: $38.8M
IRS Ruling Year: 2011
Organization Type: Corporation
Tax Deductibility: Contributions are deductible

About This Foundation

Ben And Catherine Ivy Foundation is a private corporation based in SCOTTSDALE, AZ. The foundation received its IRS ruling in 2011. It holds total assets of $299.8M. Annual income is reported at $38.8M. The foundation operates in the area of philanthropy & grantmaking. Contributions to this foundation are tax-deductible.

View 990 Filings

Financial Overview

Total Giving

$16.6M

2023-7%

Total Assets

$293.3M

2023-1%

Fair Market Value

$333.2M

2023

Net Worth

$293.3M

2023

Grants Paid

$14.8M

2023

Contributions

$540

2023

Net Investment Income

$12.9M

2023

Distribution Amount

$15.5M

2023

Total Giving by Year

$16.1M

$16.9M

$17.8M

$16.6M

Asset Growth

$297.6M

$303.2M

$296.4M

$293.3M

Investment Portfolio (2023)

Total: $55K

Government Obligations: $55K

Other Investments: $284.9M

Government Obligations (0%)

Other Investments (100%)

Expense Breakdown (2023)

Grants Paid$14.8M

Officer Compensation$397K

Occupancy$65K

Legal Fees$42K

Accounting Fees$16K

Pension & Benefits$15K

Travel & Conferences$14K

Printing & Publications$5K

Depreciation$3K

Revenue Sources (2023)

Capital Gains (Net): $6.4M
Dividends: $6.3M
Interest: $564K
Other Income: $250K
Contributions: $540

Financial Details (2023)

Total Revenue: $13.5M
Total Expenses: $16.6M
Exempt Purpose Expenses: $15.8M
Required Distribution: $15.5M
Undistributed Income: $15.2M
Total Liabilities: $12K
Excise Tax: $179K

Foundation Classification (2023)

Operating FoundationGrants to IndividualsNon-Charity GrantsLobbying ActivityExcess Business Holdings

Grantmaking Insights

Total Grants

Total Giving

$16.3M

Average Grant

$542K

Median Grant

$250K

Grant Range

Min$150

Max$5.5M

Median: $250K

Smallest grantLargest grant

Geographic Distribution of Grants

WA: $300K (1)

MN: $808K (3)

MI: $300K (1)

NY: $670K (4)

CT: $300K (1)

CA: $309K (2)

VA: $250K (1)

AZ: $11.2M (11)

NM: $300K (1)

TN: $250K (1)

FL: $569K (2)

TX: $760K (3)

AZ$11.2M (11)

MN$808K (3)

TX$760K (3)

NY$670K (4)

FL$569K (2)

CA$309K (2)

Past Grantees

Recipient	Location	Amount	Year
Neurotrials LlcPREPAYMENT OF 2023 CEREBROSPINAL FLUID ANALYSIS.	Phoenix, AZ	$5.5M	2022
Neuro Trials LlcIVY BRAIN TUMOR CENTER BUILDING EXPANSION SPECIAL GRANT AMENDMENT.	Phoenix, AZ	$5M	2022
Neurotrials LlcCEREBROSPINAL FLUID ANALYSIS WITH T-GEN.	Phoenix, AZ	$450K	2022
H Lee Moffitt Cancer CenterIN EXAMINING THE ROLE OF TUMORS CELLS IN MODULATING BONE MARROW-DERIVED MACROPHAGES AND MICROGLIA, THIS STUDY SEEKS TO TAILOR NOVEL THERAPEUTICS FOR TARGETING OF TUMOR ASSOCIATED MACROPHAGES. PAYMENT 2 OF 2.	Rochester, MN	$300K	2022
Uc San DiegoSMALL MOLECULE REGULATION OF REST PROTEIN LEVELS PROVIDES AN IDEAL PLATFORM FOR DEVELOPING A NEW THERAPEUTIC FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME. PAYMENT 1 OF 2.	La Jolla, CA	$300K	2022
Swedish Medical CenterASSESS COMBINATIONS OF SMALL MOLECULES AND IMMUNOTHERAPIES FOR KILLING GLIOBLASTOMA TUMOR CELLS IN A PERSONALIZED EX VIVO ECOSYSTEM WITH INTACT TUMOR MICROENVIRONMENT USING MULTIPLEX IMMUNOCHEMISTRY AND SPATIAL MAPPING OF CELL TYPES. PAYMENT 1 OF 2.	Seattle, WA	$300K	2022
Mayo Clinic College Of MedicineEVALUATE CANDIDATE GLIOMA CSF PROTEOMIC SIGNATURES TO HELP UNDERSTAND AND MONITOR GLIOMA EVOLUTION IN LIVING PATIENTS DURING STANDARD OF CARE AND EXPERIMENTAL IMMUNOTHERAPY. PAYMENT 1 OF 2.	Rochester, MN	$300K	2022
University Of MichiganNEW METHODS WILL BE DEVELOPED TO MEASURE THE ACTIVITY OF TUMOR METABOLIC PATHWAYS IN PATIENTS WITH GLIOBLASTOMA AND TO DETERMINE WHETHER DRUGS DESIGNED TO BLOCK THESE PATHWAYS ARE SUITABLE. PAYMENT 2 OF 2.	Ann Arbor, MI	$300K	2022
Univ Of New Mexico Health SciencesIDENTIFY MECHANISMS UNDERLYING INFLAMMATORY CELL CONTRIBUTION TO THE EMERGENCE OF THE RECURRENT TUMOR BY SINGLE-CELL ANALYSIS OF RESIDUAL DISEASE IN GLIOBLASTOMA PATIENTS. PAYMENT 2 OF 2.	Albuquerque, NM	$300K	2022
Univ Of Miami Miller School Of MediUSING PATIENT DERIVED ORTHOTOPIC XENOGRAFT MODELS AND A NOVEL IMMUNOCOMPETENT MODEL OF GBM, THE EFFICACY OF A MTl-MMP INHIBITOR IN COMBINATION WITH RADIATION/TMZ WILL BE TESTED TO DETERMINE ITS EFFECTS ON THE IMMUNE COMPONENT OF THE TUMOR MICROENVIRONMENT. PAYMENT 2 OF 2.	Miami, FL	$300K	2022
Memorial Sloan Kettering Cancer CenDISCOVER AND DESCRIBE DORMANT TUMOR CELLS CALLED CANCER STEM CELLS THAT RESIDE WITHIN ADULT GLIOMA AND ARE RESISTANT TO CURRENT THERAPIES. PAYMENT 1 OF 2.	New York, NY	$300K	2022
Yale Cancer CenterUSE OF A NOVEL TRANSFORMATIONAL PLATFORM FOR RAPID IDENTIFICATION OF TARGETS AND TREATMENTS TO INHIBIT GROWTH AND INVASION OF GLIOBLASTOMA CELLS BASED ON RAPID PATIENT SAMPLE SCREENING USING NOVEL NANO-ENGINEERING TECHNIQUES. PAYMENT 2 OF 2.	New Haven, CT	$300K	2022
University Of Tx Md Anderson CancerPROJECT SEEKS TO PRECLINICALLY OPTIMIZE NOVEL THERAPEUTIC APPROACHES FOR ATRX-DEFICIENT MALIGNANT GLIOMAS TARGETING G-QUADRUPLEX DNA SECONDARY STRUCTURE. PAYMENT 1 OF 2.	Houston, TX	$300K	2022
Mayo ClinicIDENTIFY THE ONCOGENIC SIGNALING DEPENDENCIES THAT CHARACTERIZE EACH OF THE CELLULAR SUBPOPULATIONS THAT COMPRISE A GLIOBLASTOMA TUMOR, AND FROM THIS INFORMATION CONSTRUCT A NON-TOXIC COMBINATION OF KINASE INHIBITORS TO EFFECTIVELY TREAT THIS DISEASE. PAYMENT 1 OF 2.	Jacksonville, FL	$269K	2022
University Of Tx Md Anderson CancerDEVELOP SAFE AND POTENT DRUGS THAT CAN TURN THE TUMOR IMMUNE MICROENVIRONMENT FROM SUPPRESSIVE TO PERMISSIVE, THEREBY HELPING THE IMMUNE SYSTEM TO RECOGNIZE AND KILL GLIOBLASTOMA. PAYMENT 1 OF 2.	Houston, TX	$250K	2022
Columbia University Irving MedicalTARGETING THE GLIOBLASTOMA MASTER REGULATOR CEBP A PHARMACOKINETICS AND PHARMACODYNAMICS SURGICAL STUDY OF ST101. PAYMENT 1 OF 2.	New York, NY	$250K	2022
Society Of St Vincent De PaulCENTER FOR FAMILY WELLNESS ESTABLISHED TO FOCUS ON THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES THROUGH NUTRITION, PHYSICAL ACTIVITY AND OVERALL WELLNESS. ITS CULTURALLY GROUNDED BILINGUAL EDUCATION PROGRAMS ENCOURAGE THE WHOLE FAMILY TO PARTICIPATE. PAYMENT #3.	Phoenix, AZ	$250K	2022
Virginia TechTO INHIBIT TUMOR CELL INVASION AND INVASION, TARGETED THERAPEUTICS WILL BE COUPLED TO BIOMARKER-BASED IMAGING IN PATIENT-SPECIFIC MODELS OF GLIOBLASTOMA. PAYMENT 2 OF 2.	Roanoke, VA	$250K	2022
Vanderbilt UniversityUSING SINGLE-CELL AND SYSTEMS BIOLOGY APPROACHES IN GLIOBLASTOMA, CELL SUBTYPES WILL BE MAPPED TO GLIOBLASTOMA TISSUES AND EXPERIMENTAL MODELS, ENABLING IDENTIFICATION AND PRECLINICAL TARGETING OF INTERACTIONS BETWEEN CANCER CELLS, IMMUNE CELLS, AND LOCATION SPECIFIC RESIDENT BRAIN CELLS. PAYMENT 2 OF 2.	Nashville, TN	$250K	2022
Ut Southwestern Medical CenterPRECLINICAL INVESTIGATION OF FOCUS ULTRASOUND GUIDED DELIVERY TO FACILITATE A LIPOPROTEIN-OMEGA-3 FATTY ACID-BASED BIOLOGICAL THERAPY IN GLIOBLASTOMA. PAYMENT 2 OF 2.	Dallas, TX	$210K	2022
Mayo Clinic College Of MedicineIMMUNOSTIMULATORY BACTERIAL ANTIGENS EXPRESSED IN ONCOLYTIC VIRAL PLATFORMS WILL BE TESTED IN PRECLINICAL MODELS OF GLIOBLASTOMA TO OVERCOME IMMUNE CHECKPOINT INHIBITOR RESISTANCE. PAYMENT 2 OF 2.	Rochester, MN	$208K	2022
Neuro Trials LlcDEPOSIT FOR IVY BRAIN TUMOR CENTER BUILDING LOBBY.	Phoenix, AZ	$200K	2022
Damon Runyon Cancer Research FdnINVESTIGATION OF A BIOMARKER PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS. PAYMENT 3	New York, NY	$120K	2022
Translational Genomics Research TgeNEUROLOGICAL SCIENCES INTERNSHIP PROGRAM AT TGEN DESIGNED TO GIVE HIGH SCHOOL AND UNDERGRADUATE STUDENTS INTENSIVE, HANDS-ON RESEARCH EXPERIENCE WORKING ALONGSIDE A MENTOR-SCIENTIST TO LEARN ABOUT TRANSLATIONAL RESEARCH WHILE INVESTIGATING QUESTIONS WITHIN NEUROLOGICAL SCIENCES.	Phoenix, AZ	$78K	2022
Arcs FoundationADVANCE SCIENCE AND TECHNOLOGY IN THE UNITED STATES BY PROVIDING AWARDS TO ACADEMICALLY OUTSTANDING US CITIZENS STUDYING TO COMPLETE DEGREES IN SCIENCE, ENGINEERING AND MEDICAL RESEARCH.	Artesia, CA	$9K	2022
Barrow Neurological FdnPROVIDES PHILANTHROPIC SUPPORT FOR BARROW NEUROLOGICAL INSTITUTE AT ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER. BARROW IS AN INTERNATIONAL LEADER IN THE TREATMENT, RESEARCH, AND EDUCATION OF BRAIN AND SPINAL DISEASES, CONDITIONS AND INJURIES.	Phoenix, AZ	$5K	2022
NotmykidLIFESAVING PROGRAMS, SUPPORT, RESOURCES, AND EDUCATION TO EMPOWER ADN EDUCATE YOUTH, FAMILES, AND COMMUNITIES WITH THE KNOWLEDGE AND COURAGE TO IDENTIFY AND PREVENT NEGATIVE YOUTH BEHAVIOR.	Scottsdale, AZ	$1K	2022
O'Connor InstituteADVANCES SANDRA DAY O'CONNOR'S DISTINGUISHED LEGACY AND LIFETIME WORK TO ADVANCE CIVICS EDUCATION, CIVIC ENGAGEMENT AND CIVIL DISCOURSE.	Phoenix, AZ	$500	2022
Amanda Hope RainbowBRINGING DIGNITY AND COMFORT INTO THE HARSH WORLD OF CHILDHOOD CANCER AND OTHER THREATENING DISEASES.	Phoenix, AZ	$500	2022
Lung Cancer Research FoundationIMPROVES LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER.	New York, NY	$150	2022
Translational Genomics Research TgeREFUND OF UNUSED FUNDS.	Phoenix, AZ	$-280,947	2022